GlassScriptPhysician profile
Bradley A Hobbs
NPI 1932333523
$12,494.00
in general payments reported to CMS, 2019-2025
20 companies · $2,238 in 2025
The $2,238 reported for 2025 was more than what 90% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,872 · 2020: $459 · 2021: $2,031 · 2022: $2,366 · 2023: $2,629 · 2024: $898 · 2025: $2,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,838 · Food and Beverage: $2,818 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,837.63 |
| Food and Beverage | $2,817.59 |
| Education | $109.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,681.86 | 2019-2023 | Scopis Ent, Xpress Ent Dilation System, Clarifix Cryotherapy Device |
| Aerin Medical INC. | $3,624.96 | 2019-2025 | |
| Optinose US, INC. | $818.34 | 2019-2025 | |
| Genzyme Corporation | $721.26 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $365.41 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $324.05 | 2022-2025 | Nucala |
| Intersect Ent, INC. | $262.24 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $208.97 | 2022-2025 | |
| Smith+Nephew, INC. | $130.81 | 2024-2025 | Halo, Rf20000, Ent Sinus |
| Inspire Medical Systems, INC. | $120.62 | 2025 | Inspire |
| Kerecis Limited | $70.83 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Merck Sharp & Dohme LLC | $39.33 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $29.97 | 2023 | Seglentis |
| Kaleo, INC. | $17.70 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $16.83 | 2025 | Neffy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $13.66 | 2019 | |
| Arbor Pharmaceuticals, INC. | $12.31 | 2019 | |
| Neurent Medical Limited | $11.77 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Hologic Sales and Service, LLC | $11.75 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Hobbs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.